Your browser doesn't support javascript.
loading
Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia.
Indian J Ophthalmol ; 2009 May-Jun; 57(3): 241-2
Article in En | IMSEAR | ID: sea-70491
Full text: 1 Index: IMSEAR Main subject: Photochemotherapy / Retinal Diseases / Retinal Vessels / Telangiectasis / Vitreous Body / Humans / Male / Fluorescein Angiography / Visual Acuity / Retinal Neovascularization Language: En Journal: Indian J Ophthalmol Year: 2009 Type: Article
Full text: 1 Index: IMSEAR Main subject: Photochemotherapy / Retinal Diseases / Retinal Vessels / Telangiectasis / Vitreous Body / Humans / Male / Fluorescein Angiography / Visual Acuity / Retinal Neovascularization Language: En Journal: Indian J Ophthalmol Year: 2009 Type: Article